Castle Biosciences (CSTL) EPS (Diluted) Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EPS (Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.87% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | 54.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.14% |
| Mar 31, 2026 | 23.79% |
| Dec 31, 2025 | 53.33% |
| Sep 30, 2025 | 71.81% |
| Jun 30, 2025 | 64.35% |
| Mar 31, 2025 | 2.29% |
| Dec 31, 2024 | 37.78% |
| Sep 30, 2024 | 29.38% |
| Jun 30, 2024 | 42.37% |
| Mar 31, 2024 | 18.74% |
| Dec 31, 2023 | 28.04% |
| Sep 30, 2023 | -3.78% |
| Jun 30, 2023 | -107.66% |
| Mar 31, 2023 | -236.42% |
| Dec 31, 2022 | -74.72% |
| Sep 30, 2022 | -58.55% |
| Jun 30, 2022 | 60.83% |
| Mar 31, 2022 | 7.45% |
| Dec 31, 2021 | -33.04% |
| Sep 30, 2021 | 41.51% |